5 September 2008, 12:44 pm
Bostwick Therapeutics Announces Initiation of Novel Phase I/II ...MarketWatch - 16 hours ago... Ventura, CA., to initiate the CRITICAL (CRyotherapy and IntraTumoral Immunotherapy with immature dendritic Cells (AutoLogous)) trial, a clinical trial ...... read more